Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial
在异基因造血干细胞移植预处理方案中加入inotuzumab ozogamicin的安全性和长期生存结果:一项单中心1/2期试验
期刊:American Journal of Hematology
影响因子:9.9
doi:10.1002/ajh.27254
Khouri, Issa F; Alzahrani, Kamal; Kantarjian, Hagop; Milton, Denái R; Gulbis, Alison M; Sasaki, Koji; Jain, Nitin; Short, Nicholas J; Kadia, Tapan; Daher, May; Rafei, Hind; Im, Jin S; Marin, David; Olson, Amanda L; Popat, Uday; Qazilbash, Muzaffar; Ramdial, Jeremy; Rondon, Gabriela; Srour, Samer; Kebriaei, Partow; Shpall, Elizabeth; Champlin, Richard; Jabbour, Elias J